Toxicology Reports (Jan 2021)

Toxic potential of botulinum toxin type A on senescence in a Drosophila melanogaster model

  • Farnoosh Fooladvand,
  • Vida Tahouri,
  • Maryam Baeeri,
  • Tayebeh Minaei,
  • Mahban Rahimifard,
  • Mahshid Hodjat,
  • Reza Khorasani,
  • Hamed Haghi-Aminjan,
  • Mohammad Abdollahi

Journal volume & issue
Vol. 8
pp. 1576 – 1582

Abstract

Read online

Botulinum toxin type-A (BoNT/A) application, especially neurological disorders, has been spread nowadays while it may cause side effects. The current study aimed to assess the BoNT/A dose-dependent effect on induction of aging in the Drosophila melanogaster model. The third instar larvae of Drosophila melanogaster were exposed to ¼ LC50, ½ LC50, and LC50 of BoNT/A in the Drosophila diet for 48 h while H2O2 1% was used as a positive control. After the exposure time, some larvae were collected for molecular study, including gene expression analysis, comet assay, oxidative stress markers, and the phenotype changes. BoNT/A induced dose-dependent cytotoxicity, elevated reactive oxygen species (ROS) levels, and superoxide dismutase (SOD) enzyme activity. In addition, it caused DNA damage and activated caspase-3 and -9, and reduced the body size of the fly, especially in high doses. In line with the purpose of the study, aging markers, including β-galactosidase (β-gal), p16, p21, p38, and p53, were up-regulated by BoNT/A low dose. BoNT/A activates the aging pathway in the low dose, and increasing the dose induces toxicity, including oxidative stress, DNA damage, and apoptosis.

Keywords